Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up

Thorax

Volumn 58, Issue 4, 2003, Pages 322-327

  Vonk, J M ^a   Jongepier, H ^b   Panhuysen, C I M ^c   Schouten, J P ^a   Bleecker, E R ^d   Postma, D S ^e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Beatrixoord Hospital   (Netherlands)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBON MONOXIDE; CORTICOSTEROID; SALBUTAMOL;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; DISEASE COURSE; DRUG USE; DYSPNEA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; IRREVERSIBLE AIRWAY OBSTRUCTION; LUNG ALVEOLUS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SEX DIFFERENCE; SMOKING;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 0345701349     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.4.322     Document Type: Article

References (26)

1. Gerritsen J, Koëter GH, Postma DS, et al. Prognosis of asthma from childhood to adulthood. Am Rev Respir Dis 1989;140:1325-30.
2. Panhuysen CIM, Vonk JM, Koëter GH, et al. Adult patients may outgrow their asthma. A 25-year follow-up study. Am J Respir Crit Care Med 1997;155:1267-72.
3. Roorda RJ, Gerritsen J, Aalderen van WMC, et al. Risk factors for the persistence of respiratory symptoms in childhood asthma. Am Rev Respir Dis 1993;148:1490-5.
4. Gooijer de A, Brand PLP, Gerritsen J, et al. Changes in respiratory symptoms and airway hyperresponsiveness after 27 years in a population-based sample of school children. Eur Respir J 1993;6:848-54.
5. Boulet LP, Turcotte H, Brochu A. Persistence of airway obstruction and hyperresponsiveness in subjects with asthma remission. Chest 1994;105:1024-31.
6. Roorda RJ. Childhood asthma: outcome after 20 years. Pediatr Pulmonol 2001;Suppl 18:99-102.
7. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-2000.
8. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-9.
9. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994;150:629-34.
10. Backman KS, Greenberger PA, Patterson R. Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'. Chest 1997;112:1234-40.
11. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999;14:892-6.
12. Hudon C, Turcotte H, Laviolette M, et al. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann Allergy Asthma Immunol 1997;78:195-202.
13. Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984;39:131-6.
14. Finucane KE, Greville HW, Brown PJ. Irreversible airflow obstruction. Evolution in asthma. Med J Aust 1985;142:602-4.
15. Sakai F, Gamsu G, Im JG, et al. Pulmonary function abnormalities in patients with CT-determined emphysema. J Comput Assist Tomogr 1987;11:963-8.
16. American Thoracic Society. Definitions and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Rev Respir Dis 1962;85:762-85.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
18. Elias JA. Airway remodeling in asthma. Unanswered questions. Am J Respir Crit Care Med 2000;161:S168-71.
19. Selroos O, Pietinalho A, Löfroos A-B, et al. Effect of early vs. late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
20. Booy-Noord H, Orie NGM, Cate ten HJ, et al. The influence of various drugs on the vital capacity of asthmatics. Int Arch Allergy Appl Immunol 1957;10:321-41.
21. Bork van EL. Thiazinamium methylsulfaat. Een onderzoek naar de farmacodynamiek en de klinische toepassing bij chronisch gegeneraliseerde obstructieve longaandoeningen. Thesis Rijksuniversiteit, Groningen, The Netherlands, 1978.
22. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000;105:1041-53.
23. Roorda RJ, Gerritsen J, Aalderen van WMC, et al. Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 1994;93:575-84.
24. Grol MH, Gerritsen J, Vonk JM, et al. Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. Am J Respir Crit Care Med 1999;160:1830-7.
25. Lynch DA, Newell JD, Tschomper BA, et al. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993;188:829-33.
26. 1: new insight into gender differences. Eur Respir J 1994;7:1056-61.